Literature DB >> 7554026

Reduced doses of hepatitis B vaccines: is it a good idea?

M Kane1.   

Abstract

Hepatitis B vaccines are not generic products and it cannot be assumed that all such vaccines can be used in reduced doses in order to save costs. Any use of vaccines in an unlicensed manner should only be performed in the context of a study that is approved by the national control authority and appropriate ethical review committees.

Entities:  

Keywords:  Critique; Diseases; Hepatitis--prevention and control; Vaccines--administraction and dosage; Viral Diseases

Mesh:

Substances:

Year:  1995        PMID: 7554026      PMCID: PMC2486788     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults.

Authors:  K T Goh; C J Oon; B H Heng; G K Lim
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

  1 in total
  2 in total

1.  Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults.

Authors:  K T Goh; C J Oon; B H Heng; G K Lim
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

2.  Hepatitis B vaccine development and implementation.

Authors:  Hong Zhao; Xiaoying Zhou; Yi-Hua Zhou
Journal:  Hum Vaccin Immunother       Date:  2020-03-18       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.